Insights into the molecular basis of cancer development

Current Paediatrics

Volumn 15, Issue 4, 2005, Pages 333-338

  Strahm, Brigitte ^a   Capra, Michael ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cell cycle; MYC; Oncogenes; p53; RB; Tumour suppressor genes

Indexed keywords

PROTEIN P53; PROTEIN RB1; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL GROWTH; GENETIC DISORDER; HUMAN; METASTASIS; ONCOGENE MYC; RETINOBLASTOMA; SOMATIC CELL; SUPPRESSOR GENE; TELOMERE;

EID: 27644546660     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2005.04.004     Document Type: Article

References (25)

1. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99.
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
3. Knudson Jr. AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
4. Cavenee WK, Dryja TP, Phillips RA, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-84.
5. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
6. Nurse P. A long twentieth century of the cell cycle and beyond. Cell 2000;100:71-8.
7. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
8. Malkin D. The role of p53 in human cancer. J Neurooncol 2001;51:231-43.
9. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
10. Bourdon JC, Laurenzi VD, Melino G, Lane D. p53: 25 years of research and more questions to answer. Cell Death Differ 2003;10:397-9.
11. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
12. Sheiness D, Bishop JM. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Virol 1979;31:514-21.
13. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982;79:7824-7.
14. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004;4:562-8.
15. Adams JM, Gerondakis S, Webb E, Corcoran LM, Cory S. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci USA 1983;80:1982-6.
16. Bernheim A, Berger R, Lenoir G. Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations. Cancer Genet Cytogenet 1981;3: 307-15.
17. Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience-a pediatric oncology group study. J Clin Oncol 1998;16: 2007-17.
18. Hayflick L. Mortality and immortality at the cellular level. A review. Biochemistry (Moscow) 1997;62:1180-90.
19. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
20. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
21. Bryan TM, Cech TR. Telomerase and the maintenance of chromosome ends. Curr Opin Cell Biol 1999;11:318-24.
22. Folkman J. Tumor angiogenesis. In: Holland J, editor. Cancer medicine. Baltimore: Williams and Wilkins; 1997. p. 181-204.
23. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-4.
24. Sporn MB. The war on cancer. Lancet 1996;347:1377-81.
25. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Not Rev Cancer 2002;2:563-72.